MedPath

The multicenter observational study of systemic chemotherapy for gastrointestinal and hepatobiliary-pancreatic poorly differentiated neuroendocrine carcinoma.

Not Applicable
Conditions
gastrointestinal and hepatobiliary-pancreatic poorly differentiated neuroendocrine carcinoma
Registration Number
JPRN-UMIN000005176
Lead Sponsor
ational Cancer Center Hospital-TOKYO
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

malignant carcinoid insulinoma, gastrinoma, VIPoma islet cell carcinoma

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Response rate
Secondary Outcome Measures
NameTimeMethod
Progression-free survival, Overall survival, Time to progression
© Copyright 2025. All Rights Reserved by MedPath